| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |